201 related articles for article (PubMed ID: 18415020)
1. Fracture risk and bone mineral density in Turner syndrome.
Bakalov VK; Bondy CA
Rev Endocr Metab Disord; 2008 Jun; 9(2):145-51. PubMed ID: 18415020
[TBL] [Abstract][Full Text] [Related]
2. Fracture risk, underlying pathophysiology, and bone quality assessment in patients with Turner syndrome.
Ikegawa K; Hasegawa Y
Front Endocrinol (Lausanne); 2022; 13():967857. PubMed ID: 36325455
[TBL] [Abstract][Full Text] [Related]
3. Monitoring and maintaining bone health in patients with Turner syndrome.
Chiarito M; Brunetti G; D'Amato G; Faienza MF
Expert Rev Endocrinol Metab; 2020 Nov; 15(6):431-438. PubMed ID: 33074770
[TBL] [Abstract][Full Text] [Related]
4. Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy.
Landin-Wilhelmsen K; Bryman I; Windh M; Wilhelmsen L
Clin Endocrinol (Oxf); 1999 Oct; 51(4):497-502. PubMed ID: 10583318
[TBL] [Abstract][Full Text] [Related]
5. Delay in estrogen commencement is associated with lower bone mineral density in Turner syndrome.
Nguyen HH; Wong P; Strauss BJ; Jones G; Ebeling PR; Milat F; Vincent A
Climacteric; 2017 Oct; 20(5):436-441. PubMed ID: 28523940
[TBL] [Abstract][Full Text] [Related]
6. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome.
Cleemann L; Hjerrild BE; Lauridsen AL; Heickendorff L; Christiansen JS; Mosekilde L; Gravholt CH
Eur J Endocrinol; 2009 Aug; 161(2):251-7. PubMed ID: 19447901
[TBL] [Abstract][Full Text] [Related]
7. Bone health in children and adolescent with Turner syndrome.
Nadeem M; Roche EF
J Pediatr Endocrinol Metab; 2012; 25(9-10):823-33. PubMed ID: 23426807
[TBL] [Abstract][Full Text] [Related]
8. Turner syndrome and osteoporosis.
Augoulea A; Zachou G; Lambrinoudaki I
Maturitas; 2019 Dec; 130():41-49. PubMed ID: 31706435
[TBL] [Abstract][Full Text] [Related]
9. Selective reduction in cortical bone mineral density in turner syndrome independent of ovarian hormone deficiency.
Bakalov VK; Axelrod L; Baron J; Hanton L; Nelson LM; Reynolds JC; Hill S; Troendle J; Bondy CA
J Clin Endocrinol Metab; 2003 Dec; 88(12):5717-22. PubMed ID: 14671158
[TBL] [Abstract][Full Text] [Related]
10. Turner syndrome and osteoporosis: mechanisms and prognosis.
Rubin K
Pediatrics; 1998 Aug; 102(2 Pt 3):481-5. PubMed ID: 9685448
[TBL] [Abstract][Full Text] [Related]
11. Hearing impairment and low bone mineral density increase the risk of bone fractures in women with Turner's syndrome.
Han TS; Cadge B; Conway GS
Clin Endocrinol (Oxf); 2006 Nov; 65(5):643-7. PubMed ID: 17054467
[TBL] [Abstract][Full Text] [Related]
12. The importance of estrogen replacement in young women with Turner syndrome.
Hanton L; Axelrod L; Bakalov V; Bondy CA
J Womens Health (Larchmt); 2003 Dec; 12(10):971-7. PubMed ID: 14709185
[TBL] [Abstract][Full Text] [Related]
13. Musculoskeletal analyses of the forearm in young women with Turner syndrome: a study using peripheral quantitative computed tomography.
Bechtold S; Rauch F; Noelle V; Donhauser S; Neu CM; Schoenau E; Schwarz HP
J Clin Endocrinol Metab; 2001 Dec; 86(12):5819-23. PubMed ID: 11739445
[TBL] [Abstract][Full Text] [Related]
14. A 6-Year Follow-Up of Fracture Incidence and Volumetric Bone Mineral Density Development in Girls With Turner Syndrome.
Soucek O; Schönau E; Lebl J; Willnecker J; Hlavka Z; Sumnik Z
J Clin Endocrinol Metab; 2018 Mar; 103(3):1188-1197. PubMed ID: 29300907
[TBL] [Abstract][Full Text] [Related]
15. Bone geometry and volumetric bone mineral density in girls with Turner syndrome of different pubertal stages.
Soucek O; Lebl J; Snajderova M; Kolouskova S; Rocek M; Hlavka Z; Cinek O; Rittweger J; Sumnik Z
Clin Endocrinol (Oxf); 2011 Apr; 74(4):445-52. PubMed ID: 21138463
[TBL] [Abstract][Full Text] [Related]
16. The Effect of the Rate of Increase of Estrogen Replacement Therapy on Bone Mineral Density Accrual in Young Patients with Turner Syndrome.
Brander EPA; Keenahan LA; Sangi-Haghpeykar H; Graham M; Dietrich JE
J Pediatr Adolesc Gynecol; 2023 Aug; 36(4):353-357. PubMed ID: 36934800
[TBL] [Abstract][Full Text] [Related]
17. The assessment of skeletal status in young patients with Turner syndrome by 2 densitometric techniques: Phalangeal quantitative ultrasound and dual energy X-ray absorptiometry.
Wikiera B; Mierzwicka A; Basiak A; Halupczok-Żyła J; Jędrzejuk D; Cabała M; Noczyńska A; Bolanowski M; Mikołajczyk K; Halaba ZP
Adv Clin Exp Med; 2018 Jun; 27(6):759-764. PubMed ID: 29877636
[TBL] [Abstract][Full Text] [Related]
18. Marked disproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult turner syndrome: a cross-sectional study.
Gravholt CH; Lauridsen AL; Brixen K; Mosekilde L; Heickendorff L; Christiansen JS
J Clin Endocrinol Metab; 2002 Jun; 87(6):2798-808. PubMed ID: 12050253
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of phalangeal quantitative ultrasound in identifying reduced bone mineral status and increased fracture risk in adolescents with Turner syndrome.
Vierucci F; Del Pistoia M; Erba P; Federico G; Saggese G
Hormones (Athens); 2014; 13(3):353-60. PubMed ID: 25079459
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with low bone mineral density in Turner syndrome: a multicenter prospective observational study.
Ikegawa K; Koga E; Itonaga T; Sakakibara H; Kawai M; Hasegawa Y
Endocr J; 2024 Jun; 71(6):561-569. PubMed ID: 38522940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
